Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 20 and 78 years of age.
- People who are able and willing to sign a written consent form agreeing to take part.
- People who fall into one of the following groups: those having surgery to remove part or all of the pancreas for a non-hormonal pancreas condition; those with a specific type of pancreatic cancer (pancreatic ductal adenocarcinoma) who are having pancreas surgery; those with long-term pancreas inflammation or who have had at least one previous episode of sudden pancreas inflammation; those considered at higher risk of developing type 2 diabetes, including people with slightly elevated fasting blood sugar or blood sugar levels that are higher than normal but not yet in the diabetes range; or those who have recently been diagnosed with type 2 diabetes.
- People who are able to complete the health and metabolism tests and provide the samples required by the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People younger than 20 or older than 78 years of age.
- People who are unable or unwilling to provide signed consent to participate.
- People who are pregnant or currently breastfeeding.
- People who have been diagnosed with type 1 diabetes.
- People who have taken part in another clinical trial involving an experimental medicine within the 30 days before joining this study.
- People with health conditions that would prevent them from completing the planned health and metabolism assessments.
- People who would not be able to follow the study procedures as required.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Teresa Mezza, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630156664
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Identification and Characterization of Metabolic Endotypes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.